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Summary  Left  ejection  fraction  (LVEF)  —  resulting  from  the  difference  between  end-diastolic
volume (EDV)  and  end-systolic  volume  (ESV),  divided  by  EDV  —  is  a  poor  index  of  left  ventri-
cular (LV)  systolic  performance  due  to  its  dependency  on  load  conditions,  inotropic  state  and
LV remodelling.  The  characteristic  impedance  of  the  ascending  aorta  (Zc)  integrates  factors
Abbreviations: C, pressure wave velocity; CO, cardiac output; +dP/dtmax, maximal left ventricular pressure rise during isovolumic
ontraction; Ea, effective arterial elastance; EDP, end-diastolic pressure; EDV, end-diastolic volume; Ees, left ventricular end-systolic
lastance; EF, ejection fraction; Ep, elasticity of the aorta; ESP, end-systolic pressure; ESV, end-systolic volume; HFpEF, heart failure and
reserved ejection fraction; HFrEF, heart failure and reduced ejection fraction; LV, left ventricular; m, left ventricular mass; PVR, peripheral
ascular resistance; PWV, pulse wave velocity; R, aortic radius; SV, stroke volume; VCF, mean velocity of ﬁbre shortening; Z, aortic input
mpedance; Zc, characteristic aortic impedance; |Zn|, moduli of impedance.
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opposing  LV  ejection  during  the  early  ejection  period  when  arterial  wave  reﬂection  can  be
neglected. Zc  is  related  to  the  pressure  wave  velocity  (C)  and  the  cross-sectional  area  of  the
aorta. The  aim  is  to  demonstrate  that  LV  performance  and  geometry  are  closely  related  to
the physical  properties  of  the  arterial  system.  LV  pressure-volume  loops  were  obtained  from
simultaneous  measurements  of  LV  (or  aortic)  pressure  and  LV  volume.  The  slope  Ees  (also  called
LV end-systolic  elastance)  of  the  ESP-ESV  relationship  was  assessed.  Aortic  diameters,  pressure
and ﬂow  measurements  were  synchronized  to  evaluate  C,  aortic  forward  and  backward  pressure
waves, the  elasticity  of  the  aorta  (Ep)  and  thereby  Zc.  In  contrast  to  LVEF,  LV  end-systolic  elas-
tance (Ees),  which  reﬂects  the  stiffness  of  the  chamber  at  maximal  myoﬁlament  activation,
is relatively  insensitive  to  load  conditions  and  may  be  considered  as  an  index  of  ventricular
chamber  contractility.  For  a  given  Ees  value,  the  end-systolic  pressure  (ESP)  determines  the
LV end-systolic  volume.  Ees  is  determined  by  cardiac  myocytes  contractility  and  density,  and
thereby concentric  remodelling.  A  tight  correlation  between  Zc  and  the  degree  of  LV  concen-
tric remodelling  was  found  in  hypertensive  and  in  normal  subjects.  Zc  was  found  to  increase
throughout the  full  lifespan  and  also  with  hypertension.  Both  Zc  and  wave  reﬂections  determine
aortic input  impedance  estimated  from  the  aortic  pressure-ﬂow  relationship.  Increased  arterial
stiffness resulted  in  increasing  C  and  overlap  of  forward  and  backward  waves  and  thereby  in
greater pulse  pressure  and  ESP  and  a  greater  difference  between  ESP  and  diastolic  pressure.
Ees is  an  accurate  index  of  LV  systolic  performance.  Besides  the  inotropic  state  of  myoﬁbers,
Ees depends  on  the  concentric  remodelling  and  thereby  on  the  characteristic  impedance  of  the
aorta.
© 2014  Elsevier  Masson  SAS.  All  rights  reserved.
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Résumé  La  fraction  d’éjection  (FE)  du  ventricule  gauche  (VG),  rapport  entre  le  volume  sys-
tolique (VS)  (différence  entre  le  volume  télédiastolique  [VTD]  et  le  volume  télésystolique  [VTS])
et le  VTD,  est  un  mauvais  indice  de  fonction  systolique  VG.  La  FE  dépend  certes  de  la  qualité
de pompe  VG  mais  aussi  de  son  remodelage  et  est  étroitement  dépendante  des  conditions  de
charge du  VG.  L’élastance  télésystolique  (ETS),  rapport  entre  pression  télésystolique  (PTS)  et
VTS, est  indépendante  des  conditions  de  charge  du  VG.  Elle  exprime  la  qualité  du  VG  à  dévelop-
per de  la  pression.  ETS  est  fonction  de  la  qualité  des  ﬁbres  myocardiques  et  de  leur  nombre
(remodelage  concentrique).  Le  remodelage  concentrique  est  étroitement  en  rapport  avec  les
propriétés physiques  du  système  artériel  et  en  particulier  avec  l’impédance  caractéristique  de
l’aorte (Zc).  Zc  exprime  les  « forces  » qui  s’opposent  à  l’éjection  VG  en  début  de  systole  avant
le retour  des  ondes  de  réﬂexion  (OR).  Zc  est  d’autant  plus  élevée  que  la  rigidité  aortique  est
grande (augmentation  de  la  vitesse  d’onde  C)  et  que  la  section  aortique  est  petite.  Une  relation
étroite relie  Zc  et  le  remodelage  concentrique  aussi  bien  chez  des  sujets  normotendus  lors  du
vieillissement  que  chez  les  patients  hypertendus  indépendamment  de  l’âge.  En  ﬁn  de  systole  le
chevauchement  des  ondes  de  pression  incidentes  (OI)  et  réﬂéchies  (OR)  détermine  la  PTS.  Le
chevauchement  des  OI  et  OR  est  d’autant  plus  important  que  l’amplitude  des  ondes  est  impor-
tante et  la  vitesse  d’onde  est  grande.  Pour  une  valeur  de  ETS,  PTS  détermine  le  VTS.  Zc,  OI  et
OR interviennent  ainsi  tout  au  long  de  l’éjection.  Zc  et  les  ondes  de  réﬂexion  sont  les  principaux
éléments  de  l’impédance  aortique.  Cette  dernière  relie  de  fac¸on  quantitative  pression  et  débit
dans l’aorte.  La  performance  et  le  remodelage  ventriculaire  gauche  sont  étroitement  liés  aux
propriétés  physiques  du  système  artériel.
© 2014  Elsevier  Masson  SAS.  Tous  droits  réservés.
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systolic  volume  (ESV),  divided  by  EDV  —  was  a  poor  indexBackground
Everything  that  is  simple
is  theoretically  false,  everything  that  is  complicated
is  pragmatically  unusable.
Paul  ValéryIn  the  1970s,  Merillon  and  Gourgon  performed  landmark
haemodynamic  studies  on  the  evaluation  of  left  ventricular
o
c
GLV)  performance  in  the  intact  human  circulation.  A  few
ears  earlier,  Sagawa  et  al.  had  shown  similar  results  in
ogs,  using  variably  loaded  LV  pressure-volume  loops  [1].
he  pioneers  from  Beaujon  University  Medical  Centre  soon
ecognized  that  LV  ejection  fraction  (LVEF)  —  resulting  from
he  difference  between  end-diastolic  volume  (EDV)  and  end-f  LV  systolic  performance  due  to  its  dependency  on  load
onditions,  inotropic  state  and  LV  remodelling.  Merillon  and
ourgon  consistently  demonstrated  that  LV  performance
556  J.P.  Mérillon  et  al.
Figure 1. Typical example of electrocardiogram (EKG), ﬂow and
pressure recording in a normal subject. The maximal left ventricular
pressure rise during isovolumic contraction (+dP/dt) and (+dP/dt)/P
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Figure 2. The left ventricular (LV) pressure-volume loop is con-
strained by the end-systolic pressure (ESP)-volume relationship
(ESPVR) and the end-diastolic pressure (EDP)-volume relationship
(EDPVR). The preload (LVEDP) and afterload determine the position
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fre derivative of left ventricular pressure (LVP). Ao: aortic; Ao P:
ortic pressure; P: ventricular pressure.
nd  geometry  were  tightly  related  to  the  physical  proper-
ies  of  the  arterial  system  in  normal,  hypertensive  and  heart
ailure  patients  [2—18].
The  LV  pump  is  designed  to  generate  pressure  to  eject
 systolic  volume  of  blood  (the  stroke  volume  [SV])  into  a
igh-pressure  system.  Series  of  LV  pressure-volume  loops
re  obtained  using  variable  loads  in  order  to  assess  LV
erformance,  which  includes  systolic  properties  and  ﬁlling
apacities.  The  forces  that  oppose  LV  ejection  include:  iner-
ia  forces  related  to  blood  mass  acceleration;  capacitive
orces  related  to  aortic  wall  distensibility,  which  opposes
ortic  volume  variation;  resistive  forces  related  to  wall
nd  blood  viscosity  (which  are  negligible  in  large  vessels);
eﬂected  waves  arising  from  the  arterial  tree;  and  periph-
ral  vascular  resistance  (PVR),  which  determines  the  mean
rterial  pressure.
The  ﬁrst  four  of  these  forces  determine  the  aortic  input
mpedance  (Z)  to  pulsatile  blood  ﬂow,  while  PVR  represents
he  opposition  to  steady  ﬂow  (i.e.  cardiac  output  [CO]).
he  change  in  pressure  in  the  proximal  aorta  resulting  from
 given  change  in  ﬂow  in  the  absence  of  wave  reﬂection
eﬁnes  the  characteristic  aortic  impedance  (Zc);  this  occurs
ithin  the  ﬁrst  third  of  systole  before  the  reﬂected  pulse
ave  has  returned  to  the  ascending  aorta.
ethods
eft ventricular variables
atients  were  investigated  invasively  at  a  time  when  Doppler
chocardiography  had  not  been  developed  (Fig.  1).  The
V  mass  (m)  was  calculated  by  using  the  method  of
ackley  et  al.,  from  anteroposterior  ﬁlm  of  the  opaci-
ed  left  ventricle  [19].  CO  was  measured  by  right  heart
atheterization,  using  the  dye  (indocyanine  green)  dilution
echnique.  LV  pressure-volume  loops  were  obtained  from
imultaneous  measurements  of  LV  (or  aortic)  pressure  and
V  volume  (Fig.  2).  The  LV  pressure  was  measured  with
igh-ﬁdelity  micromanometer-tipped  catheters  (Millar  5F),
hich,  unlike  a  ﬂuid-ﬁlled  catheter,  yield  accurate  pressure
a
t
s
vnd shape of the loop. EDV: end-diastolic volume; ESV: end-systolic
olume; Vd: the extrapolated volume intercept at zero pressure.
easurements,  without  phase  or  frequency  distortion.  The
V  volumes  were  measured  by  single-plane  cineangiogra-
hy  (50  frames/second)  at  a  right  anterior  oblique  incident
ngle.  The  end-systolic  pressure  (ESP)  is  the  pressure  corre-
ponding  to  the  LVESV  and  not  to  the  dicrotic  notch  of  the
ortic  pressure  (however,  in  routine  practice  both  values  are
imilar).  The  slope  Ees  (also  called  LV  end-systolic  elastance)
f  the  ESP-ESV  relationship  was  assessed.
ortic input impedance
he  elastic  properties  or  stiffness  of  the  proximal  aorta  were
omprehensively  studied  by  these  pioneers  before  pulse
ave  velocity  (PWV)  measurement  devices  or  high  reso-
ution  wall  tracking  systems  became  available.  The  aortic
ressure  was  measured  above  the  Valsalva  sinuses  with  a
illar  micromanometer.  Aortic  diameters  were  measured
n  cineangiograms  (50  frames/second)  in  an  oblique  left
nterior  view.  Blood  ﬂow  velocity  was  measured  by  an
lectromagnetic  catheter-tip  velocity  transducer  placed  in
he  ascending  aorta.  Aortic  diameters,  pressure  and  ﬂow
easurements  were  synchronized  to  evaluate  PWV,  aortic
orward  and  backward  pressure  waves,  the  elasticity  of  the
orta  (Ep)  and  thereby  Zc,  obtained  by  averaging  values  of
he  moduli  of  impedance  (|Zn|)  above  4 Hz.  Zc  as  a  mea-
ure  of  arterial  wall  stiffness  correlates  with  pressure  wave
elocity  (C)  and  aortic  radius  (R).
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Figure 3. A. Pressure-volume loops before (ﬁlled circle) and dur-
ing nitroprusside infusion (open circle). Note that in spite of a
smaller end-systolic pressure drop, the decrease in left ventricu-
lar end-systolic volume and resulting increase in stroke volume are
larger in the failing heart than in the normal heart. P: pressure; V:
volume. B. Pressure-volume loops at basal state (ﬁlled circle) and
during post extrasystolic potentiation (open circle). Note that the
increase in stroke volume (resulting from a larger decrease in left
ventricular end-systolic volume) is higher in the failing heart (right)
than in the normal heart (left). P: pressure; V: volume.Left  ventricular  performance  and  arterial  system  
Left ventricular performance
Left ventricular systolic performance
LV  pressure-volume  diagrams  were  analysed  with  changes
in  loading  conditions,  inotropism  and  heart  rate  in  normal
subjects  and  in  patients  with  cardiomyopathy  [11].  Infusion
of  sodium  nitroprusside  [9,12]  was  used  to  reduce  preload
and  afterload  (10—15  mmHg  LV  end-diastolic  pressure  [EDP]
decrease  and  20  mmHg  mean  aortic  pressure  decrease).
Angiotensin  infusion  was  used  to  speciﬁcally  increase  after-
load  (20  mmHg  mean  aortic  pressure  increase)  [5]. Post
extrasystolic  potentiation  [7]  was  triggered  by  a  right  ventri-
cular  stimulus  to  alter  inotropic  state.  Heart  rate  increase
was  obtained  by  right  atrial  pacing  [8].  The  investigators
found  that  Ees  was  not  modiﬁed  by  nitroprusside  (Fig.  3A)
or  angiotensin  in  either  group,  while  mean  velocity  of  ﬁbre
shortening  (VCF)  and  LVEF  increased  after  vasodilation  and
decreased  after  vasoconstriction  in  congestive  heart  fail-
ure  patients  [15].  During  post  extrasystolic  potentiation
Ees,  EF,  +dP/dtmax and  VCF  all  increased  in  normal  subjects
and  in  patients  with  heart  failure  and  reduced  EF  (HFrEF)
(Fig.  3B).  Right  atrial  pacing  increased  +dP/dtmax and  Ees,
while  VCF  and  EF  were  not  altered  in  normal  and  congestive
heart  failure  subjects.  These  studies  showed  that,  in  con-
trast  to  EF,  Ees  is  relatively  insensitive  to  load  conditions
and  may  be  considered  as  an  index  of  ventricular  chamber
(but  not  of  myocyte)  contractility.  Thus,  the  variable  Ees
appears  useful  in  discriminating  a  normal  from  a  failing  ven-
tricle.  The  Ees  is  typically  close  to  2.0  mmHg/mL  in  normal
hearts,  <  1.0  mmHg/mL  in  failing  dilated  hearts  and  about
4.0  mmHg/mL  in  hypertrophic  hearts.
The  same  authors  found  that  Ees  increases  with  age
and  in  hypertensive  subjects  [6,13,14].  The  reduction  in
CO  observed  in  older  and/or  hypertensive  patients  is  not
associated  with  a  decrease  in  LV  performance,  but  with
lower  LVESV  and  SV  resulting  from  concentric  LV  remod-
elling.  Besides  indicating  chamber  contractility,  Ees  reﬂects
the  stiffness  of  the  chamber  at  maximal  myoﬁlament  acti-
vation.  Concentric  remodelling  and  Ees  are  thus  keys  in  LV
adaptation  to  chronic  pressure  overload.  Consistent  with
this,  Kawaguchi  et  al.  found  that  Ees  is  higher  in  heart  failure
with  preserved  ejection  fraction  (HFpEF)  and  hypertensive
patients  compared  with  control  subjects  [20].
Clinical applications of left ventricular
pressure-volume loops
Interestingly,  the  acute  effects  of  vasodilating  or  inotropic
therapy  on  LVESV  and  SV  regulation  may  be  predicted  from
serial  LV  pressure-volume  loops  (Fig.  3A).
Considering  a  given  HFpEF  patient  with  ESP1 =  150  mmHg
and  Ees  =  5  mmHg/mL,  then  LVESV1 =  150/5  =  30  mL.  A  20
mmHg  reduction  in  ESP  with  a  vasodilator  produces  a  mod-
est  reduction  in  ESV:  LVESV2 =  ESP2/Ees  =  130/5  =  26  mL.  The
SV  gain  is  therefore  modest  (ESV1 —  ESV2 =  30  —  26  =  4  mL).
For  a  given  patient  with  heart  failure  and  systolic  dys-
function,  with  ESP1 =  100  mmHg  and  Ees  =  0.5  mmHg/mL,
LVESV1 =  100/0.5  =  200  mL.  A  10  mmHg  afterload  reduction
produces  a  signiﬁcant  ESV  decrease:  LVESV2 =  90/0.5
=  180  mL.  The  predicted  SV  increase  is  200  —  180  =  20  mL.
5 J.P.  Mérillon  et  al.
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Figure 4. A. Left ventricular pressure-volume loops in age-
matched normotensive and hypertensive subjects. The end-
diastolic pressure-volume relationship and end-systolic pressure-
volume relationship are both shifted leftward and upward. LV
ejection fraction remains, however, unchanged. P: pressure; V: vol-
ume. B. Age-related changes in left ventricular pressure-volume
loops, illustrating the progressive development of a ‘closed ventri-
cle’. The end-diastolic pressure-volume relationship shifts leftward
and upward with age (diastolic stiffening); end-systolic pressure
and end-systolic volume are shifted leftward (higher left ventricular
end-systolic elastance). Left ventricular ejection fraction does not
change signiﬁcantly, whereas the stroke volume is being reduced
due to a greater reduction in left ventricular end-diastolic volume58  
his  may  partially  explain  the  contrasting  results  of  renin-
ngiotensin  blockade  in  HFrEF  patients  (CONSENSUS)  [21]
nd  HFpEF  patients  (I-PRESERVE)  [22].  Similarly,  inotropic
herapy  is  unlikely  to  improve  HFpEF  patients  due  to  the
lready  heightened  Ees,  while  patients  with  HFrEF  with  low
es  beneﬁt  from  inotropism.
Hyperthyroidism  is  a  known  cause  of  congestive  heart
ailure.  Merillon  et  al.  [18]  assessed  LV  function  in  seven
yperthyroid  subjects  in  the  basal  state  and  after  15  mg
ntravenous  propranolol.  Higher  CO  and  +dP/dtmax, lower
VR,  but  similar  Ees  were  found  in  hyperthyroidism
ompared  to  normal  subjects.  Propranolol  administration
esulted  in  reduced  SV  and  CO.  Higher  LVESV  and  thereby
ower  Ees  were  found  following  propranolol  administration.
hese  ﬁndings  conﬁrm  that,  in  clinical  practice,  beta-
drenergic  blockade  should  be  cautiously  administered  in
atients  with  thyrotoxicosis.
eft ventricular ﬁlling capacities
he  authors  also  demonstrated  a  reduction  in  LV  distensi-
ility  with  ageing  and  hypertension.  LVEDP  was  found  to
ncrease  with  age  and  hypertension  despite  a  reduction
n  LVEDV  (Fig.  4A  and  B).  These  ﬁndings  suggest  that  the
ntire  diastolic  pressure-volume  relationship  is  shifted  left-
ard  and  upward  with  progressive  concentric  remodelling
Fig.  5)  [6,13,14].  Whether  diastolic  stiffness  is  intrinsically
eightened  in  HFpEF  that  affects  patients  with  longstanding
ypertension  remains  a  subject  of  debate  [23].
These  haemodynamic  observations  also  suggest  that  dia-
tolic  time  lengthening  is  harmful  in  HFpEF  patients  with
estrictive  ﬁlling,  who  often  also  have  mild  anaemia.  In
hese  patients,  bradycardia  reduces  CO  and  thereby  oxy-
en  supply,  and  increases  LVEDP,  while  heart  rate  increase
llows  for  CO  augmentation  (e.g.  during  exercise).  Of  note,
on-dihydropyridine  calcium  blockers  and  beta-blockers  fail
o  produce  an  improvement  in  these  patients.  Consistently,
orlaug  et  al.  found  that  chronotropic  incompetence  is  a
ajor  determinant  of  the  pathophysiology  of  HFpEF  [24].
he  RESET  trial  is  currently  testing  the  hypothesis  that  pac-
ng  may  improve  HFpEF  patients  [25].  Conversely,  the  results
f  a  mortality  trial  testing  ivabradine  —  a  current  If  channel
locker  that  speciﬁcally  decreases  heart  rate  —  in  an  HFpEF
opulation  are  urgently  awaited.
he arterial tree
VR  is  often  assimilated  to  the  force  that  opposes  LV  out-
ow,  whereas  PVR  represents  only  the  distal  impedance  of
he  arterial  system  to  a  steady  ﬂow  (0  Hz).  In  contrast,  Z  is
he  true  LV  afterload,  accounting  for  a  pulsatile  ﬂow.  Zc  is
elated  to  C  and  the  cross-sectional  area  of  the  aorta,  and  is
ndeed  tightly  dependent  on  the  aortic  pressure-radius  rela-
ionship,  which  is  curvilinear  and  highly  variable  between
ubjects  (Fig.  6).  The  smaller  the  aortic  radius  and  the  higher
he  aortic  stiffness  and  SV,  the  higher  the  aortic  pressure.  In
ormal  subjects,  Zc  represents  7—8%  of  the  systemic  resis-
ance.  The  resulting  uncoupling  between  aortic  impedance
t  0  Hz  (distal  resistance  to  steady  ﬂow),  which  is  around
200  dyn  s  cm−5 in  normal  subjects,  and  Zc,  which  is  around
0  dyn  s  cm−5,  is  a  major  advantage  for  the  cardiac  work.
than in left ventricular end-systolic volume. P: pressure; V: volume.
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Figure 5. Relationship between the left ventricular mass (m)/left
ventricular end-diastolic volume (LVEDV) ratio and age. Note a
substantial increase in m/LVEDV in subjects aged > 50 years and a
higher value at any given age in hypertensive subjects (open circles)
compared with in normotensive subjects (ﬁlled circles). A higher
m/LVEDV ratio enhances LV chamber contractility to match higher
arterial load.
Merillon  et  al.  demonstrated  that  overall  aortic  stiff-
ness  increases  throughout  the  full  lifespan  and  also  with
diastolic  blood  pressure  and  hypertension  [6,13,14]. How-
ever,  despite  a  progressive  increase  in  C,  Zc  falls  slightly
during  early  adulthood  due  to  the  natural  increase  in  aortic
diameter  that  occurs  prior  to  the  age  of  60  years  (Fig.  7A)
[26].  In  normal  subjects,  angiotensin  infusion  increased  Zc
to  a  variable  extent,  indicating  that  the  aortic  radius  does
not  increase  as  much  as  C.  Despite  a  substantial  decrease
in  mean  blood  pressure  and  PVR,  Zc  decreased,  increased
or  remained  unchanged  during  nitroprusside  infusion  in
hypertensive  patients  due  to  the  individually  variable  aortic
pressure-radius  relationship  [3].  A  tight  correlation  between
Zc  and  the  degree  of  LV  concentric  remodelling  (m/LVEDV)
was  found  in  hypertensive  and  in  normal  subjects  (Fig.  7B)
Figure 6. Curvilinearity of the aortic pressure-radius relation-
ship. As the distending pressure rises, a greater proportion of the
load is borne by the collagenous components rather than elastic
components of the aortic wall. Wide distribution of this relation-
ship in both normal (I) and hypertensive subjects (II) means that
several points should be assessed to predict changes in pulse wave
velocity and characteristic aortic impedance when pressure change
occurs in one individual and for comparing individuals. P: pressure;
R: radius.
Figure 7. A. Relationship between the characteristic impedance
of the ascending aorta (Zc) and age in normal (ﬁlled circles) and
hypertensive (open circles) subjects. Note that Zc falls slightly dur-
ing early adulthood and then increases steeply in older people.
The increase in aortic diameter in early adulthood may account
for the reduction in Zc even as pulse wave velocity increases.
B. Relationship between left ventricular mass (m)/left ventricular
end-diastolic volume (LVEDV) and the characteristic impedance of
the ascending aorta (Zc) in normal (ﬁlled circles) and hyperten-
sive (open circles) patients. Concentric remodelling is an essential
mechanism of LV adaptation to chronic pressure overload.
5 J.P.  Mérillon  et  al.
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Conclusions
Merillon  and  Gourgon  elegantly  demonstrated  that  Ees  is
an  accurate  index  of  LV  systolic  performance.  Besides  the
inotropic  state  of  myoﬁbers,  Ees  depends  on  the  concentric
remodelling  and  thereby  on  the  characteristic  impedance
of  the  aorta.  The  correlation  between  Zc  and  m/LVEDV  is
a  key  feature  in  hypertension  and  ageing  (Fig.  7B).  The
degree  of  concentric  LV  remodelling  estimated  by  the  ratio
m/LVEDV  is,  in  turn,  associated  with  increased  diastolic
stiffness  and  Ees.  Accordingly,  LV  pressure-volume  loops
are  shifted  upward  and  leftward  in  older  or  hypertensive
subjects  (Fig.  4A  and  B).  These  changes  produce  speciﬁc
responses  to  changes  in  load  conditions  and  therapeutics.
The  greater  reduction  in  LVEDV  than  in  LVESV  yields  features
of  a  ‘closed  ventricle’  (as  in  severe  hypertrophic  cardiomy-
opathy),  where  current  therapeutic  options  (vasoactive  or
inotropic)  lead  to  unsatisfying  results  [22].
In  the  1990s,  Kelly  et  al.  developed  a  simple  variable
(effective  arterial  elastance  [Ea]  =  ESP/SV),  which  combines
mean  and  pulsatile  loading  more  conveniently  than  Zc  [28].
In  many  studies,  ventriculoarterial  coupling  is  estimated  by
the  ratio  Ea/Ees.  Ea  and  Ees  are  matched  in  healthy  persons
and  in  hypertensive  or  compensated  HFpEF  patients;  Ea/Ees
ratios  for  optimal  function  range  between  0.6  and  1.0.
Afterload  mismatch  occurs  when  Ees  falls  and/or  Ea  rises,
resulting  in  a  rise  in  Ea/Ees  and  thereby  reduced  ventri-
cular  performance  and  metabolic  efﬁciency  [29].  Therapies
reducing  Ea  help  to  restore  efﬁcient  ventriculovascular  cou-
pling.  It  is  worth  noting  in  recent  studies  that  the  use
of  ESP  —  non-invasively  estimated  as  0.9  ×  systolic  blood
Figure 8. Normotensive patient receiving a vasodilator (V.D.)
(nicergoline is an ergot alkaloid derivative that acts as a potent
alpha-1A adrenergic receptor antagonist). Note that besides a mean
and systolic aortic pressure decrease, the difference between end-60  
6].  Of  note,  the  inconstant  regression  of  LV  hypertrophy
ith  the  use  of  antihypertensive  medications  might  be  par-
ially  explained  by  the  variable  change  in  Zc.
Patients  with  cardiomyopathy  have  increased  PVR,
esulting  in  increased  wave  reﬂection,  while  Zc  is  not  dif-
erent  from  that  in  normal  subjects  [2].  In  patients  with
ardiomyopathy,  nitroprusside  infusion  increased  SV  and  CO,
ecreased  PVR  and  wave  reﬂection,  and  produced  variable
hanges  in  Zc.  This  shows  once  again  that  there  is  no  corre-
ation  between  Zc  and  PVR  [2].
The  aortic  pressure  wave  is  the  algebraic  sum  of  a  for-
ard  or  incident  wave  (generated  by  the  LV  pump)  and  of  a
ackward  or  reﬂected  wave.  These  reﬂections  arise  in  any
oint  of  impedance  rupture  in  the  arterial  system  (bifurca-
ions,  lumen  narrowing,  arterioles,  etc.).  Besides  arterial
tiffness,  the  ﬁnal  shape  of  the  pressure  wave  depends  on
he  site  of  the  recording.  As  the  peripheral  arteries  are  close
o  the  reﬂection  sites,  the  reﬂected  wave  occurs  early  at  the
mpact  of  the  forward  wave,  and  the  waves  are  summed  up
n  systole.  In  contrast,  as  the  ascending  aorta  is  distant  from
he  reﬂecting  sites,  the  reﬂected  wave  occurs  later  in  dias-
ole  in  subjects  with  low  PWV  (low  stiffness)  or  in  systole  in
ubjects  with  high  PWV  or  a  long  LV  ejection  time.  Using  the
esterhof  model,  Merillon  et  al.  [4]  calculated  the  coefﬁ-
ient  of  reﬂection  in  three  groups:  normal,  hypertensive  and
ardiomyopathy  patients.  In  hypertensive  patients  or  during
ngiotensin  infusion,  increasing  arterial  stiffness  and  mean
ortic  pressure,  and  thereby  increasing  PWV  amplitudes  and
verlap  of  forward  and  backward  waves,  resulted  in  greater
ulse  pressure  and  ESP  and  a  greater  difference  between
SP  and  diastolic  pressure.  In  contrast,  during  nitroprusside
nfusion,  the  shape  of  the  pressure  wave  in  hypertensive
atients  became  dicrotic  due  to  more  distal  sites  of  reﬂec-
ion,  with  ESP  becoming  similar  to  diastolic  pressure.  In
ddition,  the  lower  mean  aortic  pressure  increased  aortic
ompliance  and  thereby  reduced  PWV.  Similarly,  in  patients
ith  cardiomyopathy,  the  arterial  pressure  wave  showed
 dicrotic  morphology  due  to  decreased  SV  and  ejection
ime.
linical implication of Zc: intra-aortic balloon
ounterpulsation
he  use  of  intra-aortic  balloon  counterpulsation  is  common
n  cardiogenic  shock  management.  Ascending  aortic  pres-
ure  is  artiﬁcially  decreased  during  systole  and  increased
uring  diastole.  Therapeutic  goals  of  intra-aortic  balloon
ounterpulsation  include  CO  increase,  myocardial  oxygen
onsumption  decrease  and  greater  myocardial  blood  ﬂow.
ortic  emptying  during  diastole  results  in  aortic  diame-
er  and  pressure  reduction  after  balloon  deﬂation.  Aortic
iameter  reduction  is  associated  with  an  increase  in  aor-
ic  compliance  and  thereby  a  decrease  in  PWV.  Gourgon
bserved  that  the  reduction  in  Zc  may  be  hindered  by  the
eduction  in  aortic  diameter,  especially  in  patients  with  a
orizontal  aortic  pressure-radius  relationship  curve  (unpub-
ished  data).  Interestingly,  the  recent  SHOCK  II  IABP  trial
ailed  to  show  any  beneﬁt  of  intra-aortic  balloon  counter-
ulsation  in  the  management  of  post  myocardial  infarction
ardiogenic  shock  [27].
systolic pressure and diastolic aortic pressure falls dramatically,
producing a dicrotic morphology of blood pressure. C: control;
+dP/dt: maximal left ventricular pressure rise during isovolumic
contraction; ECG: electrocardiogram; P: pressure.
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pressure  —  to  derive  Ea  may  produce  erroneous  ﬁndings,  as
ESP  may  be  similar  to  diastolic  blood  pressure,  such  as  in
patients  receiving  vasodilators  or  with  a  reduced  SV  (Fig.  8).
Interestingly,  numerous  studies  over  the  past  decade
have  shown  that  pulse  pressure  and  carotid-femoral  PWV
as  non-invasive  estimation  of  arterial  impedance  are  associ-
ated  with  the  risk  of  major  cardiovascular  events  [30].
Finally,  non-invasive  imaging-derived  strain  (change  in
length  per  unit  length)  is  considered  by  most  clinicians  to
be  the  ‘Rosetta  Stone’  of  LV  systolic  function.  Neverthe-
less,  strain  is  deformation  of  myocardium  produced  by  the
application  of  stress  (force  per  unit  of  cross-sectional  area).
Concomitant  LV  pressure  and  remodelling  measurements
are  therefore  needed  to  interpret  systolic  strain  alterations
[31].  Systolic  strain  alone  may  not  give  more  information
than  LVEF.
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Appendix A. Formulae and indices
Left ventricular indices
Angiographical  SV:  the  difference  between  LVEDV  and
LVESV;  SV  may  be  also  calculated  with  CO/heart  rate,
obtained  using  the  indocyanine  green  dilution  technique;
EF  =  SV/LVEDV  =  (LVEDV  —  LVESV)/LVEDV.
VCF:  the  mean  velocity  of  ﬁbre  shortening  cor-
rected  for  equatorial  end-diastolic  diameter  (EDD);
VCF  =  (EDD  —  ESD)/EDD  ×  ejection  time,  where  ESD  is  the
end-systolic  diameter.
+dP/dtmax:  the  maximal  LV  pressure  rise  during  isovolumic
contraction;  this  index  is  highly  dependent  on  preload  and
heart  rate.
ESPVR:  end-systolic  pressure-volume  relationship;
LVESP  = Ees  ×  (LVESV  —  Vd),  where  Vd  is  the  LV  volume  at
zero  pressure  and  negligible  compared  with  ESV.
Ees:  end-systolic  elastance  (the  slope  of  the  ESPVR):
Ees  =  LVESP/LVESV  or  LVESV  =  Ees/LVESP.
LVEF  =  1  —  (LVESV/LVEDV).
LVESV  = LVESP/Ees.
LVEDP  =  Po  ekp.LVEDV,  thus  LVEDV  =  Log  (LVEDP/Po)/kp
(where  kp  is  the  LV  chamber  stiffness  constant  and  Po  is  the
statistical  extrapolated  pressure  intercept  at  zero  volume
after  adjustment  of  the  exponential  diastolic  PV  relation-
ship).LVEF  =  1  —  (LVESP/Ees)  ×  (kp/Log[LVEDP/Po]);  this  equa-
tion  shows  that  EF  is  not  an  index  of  LV  systolic  performance.
LV  pressure  (P),  generated  by  the  development  of  myoﬁ-
bre  tension  (T)  during  the  isovolumic  phase,  and  LV  geometry561
re  linked  by  Laplace’s  law:  T  =  P  ×  (r/h)  (where  r  is  the
adius  and  h  is  the  LV  wall  thickness  at  end-diastole)  ∼
 ×  (LVEDV/m)  or  P/(m/LVEDV),  showing  that  progressive
oncentric  remodelling  allows  for  LV  wall  tension  reduction.
rterial tree
ortic  compliance  =  V/P,  the  change  in  aortic  volume  cor-
esponding  to  the  pulse  pressure.
Ep:  Peterson’s  pressure  strain  elastic  modulus;
p  =  Ro  ×  P/R,  where  Ro  is  the  minimal  or  diastolic
nternal  aortic  radius  and  P  is  the  pressure  difference
orresponding  to  the  difference  in  radius  R.
C:  pressure  wave  velocity,  estimated  by  the  square  root
f  Ep/2 (Moens-Korteweg  equation),  where    is  the  density
f  blood.
Zc:  characteristic  impedance  of  the  ascending  aorta;
c  =  C/R2,  where    is  the  density  of  blood  and  R2 is
he  area  of  cross-sectional  aorta;  the  aortic  impedance
ncreases  when  the  aortic  radius  decreases  and/or  stiffness
ncreases.
|Zn|:  the  moduli  of  impedance,  obtained  by  dividing  the
odulus  of  each  pressure  harmonic  |Pn|  by  the  correspond-
ng  ﬂow  modulus  |Qn|.
PVR:  peripheral  vascular  resistance;  the  ratio  of  the  mean
alues  of  P  and  Q  when  aortic  pressure  and  ﬂow  are  simulta-
eously  measured  in  the  aorta  or  (mean  BP  —  RAP)/CO  using
ight  heart  catheterization,  where  BP  is  blood  pressure  and
AP  is  right  arterial  pressure.
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